Bullet flag-united-kingdom flag-ireland

THIS WEBSITE IS INTENDED FOR HEALTHCARE PROFESSIONALS IN THE UK & IRELAND*

  • Transplantation

Can AI Help Optimise the Utilisation of Marginal Organs in Transplantation?

Decision-making around expanded-criteria organs is inherently complex and fraught with critical challenges. Clinicians often face the pressure of making quick, high-stakes decisions with limited information, balancing the urgent need for organs against potential risks to recipients.1

Misjudgments can lead to either the rejection of viable organs or the acceptance of organs with poor function and high risks of failure, both of which have significant consequences for patients awaiting transplants.

In this presentation, Dr Georgios Kourounis and Dr Tobi Ayorinde discuss the OrQA2 and PITHIA3 projects. The speakers highlight the benefits of integrating AI into clinical decision-making, as well as exploring the associated risks and ethical considerations with its application for marginal organ transplantation.

This video offers an opportunity for viewers to learn how AI tools can collaborate with clinicians to increase confidence in accepting or rejecting marginal organs, and ultimately optimise patient care.

References

1. NHS Blood and Transplant. Taking Organ Utilisation to 2020 https://bts.org.uk/wp-content/uploads/2018/01/odt-organ-utilisation-strategy.pdf

2. Organ Quality Assessment. https://info.orqa.uk/

3. The Pre-Implantation Trail of Histopathology In renal transplant Allografts. https://pithia.co.uk/

We hope that you found the content valuable. To ensure that we continue to provide topics and content of interest, we would very much value your feedback by completing a short questionnaire.

  • Dr Georgios Kourounis

    General Surgery Registrar and Clinical Research Associate

    Read biography
  • Dr Tobi Ayorinde

    NIHR Clinical Lecturer

    Read biography